Comprehensive allelotype and genetic analysis of 466 human nervous system tumors

被引:129
作者
von Deimling, A
Fimmers, R
Schmidt, MC
Bender, B
Fassbender, F
Nagel, J
Jahnke, R
Kaskel, P
Duerr, EM
Koopmann, J
Maintz, D
Steinbeck, S
Wick, W
Platten, M
Müller, DJ
Przkora, R
Waha, A
Blümcke, B
Wellenreuther, R
Meyer-Puttlitz, B
Schmidt, O
Mollenhauer, J
Poustka, A
Stangl, AP
Lenartz, D
von Ammon, K
Henson, JW
Schramm, J
Louis, DN
Wiestler, OD
机构
[1] Charite Humboldt Univ, Inst Neuropathol, Dept Neuropathol, D-13353 Berlin, Germany
[2] Univ Bonn, Med Ctr, Dept Neuropathol, D-5300 Bonn, Germany
[3] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany
[4] Deutsch Krebsforschungszentrum, Div Mol Genome Anal, Heidelberg, Germany
[5] Univ Cologne, Dept Stereotact & Funct Neurosurg, Cologne, Germany
[6] Univ Zurich, Dept Neurosurg, Zurich, Switzerland
[7] Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA
[8] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA
[9] Massachusetts Gen Hosp, Mol Neurooncol Lab, Boston, MA 02114 USA
[10] Harvard Univ, Sch Med, Boston, MA USA
关键词
allelotype; brain; molecular genetics; mutation; tumor;
D O I
10.1093/jnen/59.6.544
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brain tumors pose a particular challenge to molecular oncology. Many different tumor entities develop in the nervous system and some of them appear to follow distinct pathogenic routes. Molecular genetic alterations have increasingly been reported in nervous system neoplasms. However. a considerable number of affected genes remain to be identified. We present here a comprehensive allelotype analysis of 466 nervous system tumors based on loss of heterozygosity (LOH) studies with 129 microsatellite markers that span the genome. Specific alterations of the EGFR. CDK4. CDKN2A, TP53. DMBTI. NF2, and PTEN genes were analyzed in addition. Our data point to several novel generic loci associated with bl ain tumor development, demonstrate relationships between molecular changes and histopathological features. and further expand the concept of molecular tumor variants in neuro-oncology. This catalogue may provide a valuable framework Tol future studies to delineate molecular pathways in many types of human central nervous system tumors.
引用
收藏
页码:544 / 558
页数:15
相关论文
共 51 条
  • [41] ASSOCIATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR GENE AMPLIFICATION WITH LOSS OF CHROMOSOME-10 IN HUMAN GLIOBLASTOMA-MULTIFORME
    VONDEIMLING, A
    LOUIS, DN
    VONAMMON, K
    PETERSEN, I
    HOELL, T
    CHUNG, RY
    MARTUZA, RL
    SCHOENFELD, DA
    YASARGIL, MG
    WIESTLER, OD
    SEIZINGER, BR
    [J]. JOURNAL OF NEUROSURGERY, 1992, 77 (02) : 295 - 301
  • [42] VONDEIMLING A, 1992, CANCER RES, V52, P4277
  • [43] VONDEIMLING A, 1993, BRAIN PATHOL, V3, P19
  • [44] DELETIONS ON THE LONG ARM OF CHROMOSOME-17 IN PILOCYTIC ASTROCYTOMA
    VONDEIMLING, A
    LOUIS, DN
    MENON, AG
    VONAMMON, K
    PETERSEN, I
    ELLISON, D
    WIESTLER, OD
    SEIZINGER, BR
    [J]. ACTA NEUROPATHOLOGICA, 1993, 86 (01) : 81 - 85
  • [45] VONDEIMLING A, 1994, CANCER RES, V54, P1397
  • [46] VONDEIMLING A, 1993, NEUROPATH APPL NEURO, V19, P524
  • [47] VONDEIMLING A, 1992, CANCER RES, V52, P2987
  • [48] A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors
    Waha, A
    Rollbrocker, B
    Wiestler, OD
    vonDeimling, A
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1996, 5 (02) : 147 - 150
  • [49] Weber RG, 1996, ONCOGENE, V13, P983
  • [50] WELLENREUTHER R, 1995, AM J PATHOL, V146, P827